Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism DNA inhibitors(DNA inhibitors), TSLPR inhibitors(cytokine receptor like factor 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Molecular FormulaC33H36N4O6 |
InChIKeyYMTZZJOPSATRTO-GOTSBHOMSA-N |
CAS Registry1595275-71-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | - | - |